Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FST Life Sciences
AddedMar 20, 2024
UpdatedJun 18, 2026
FST Life Sciences

FST Life Sciences

Pre-Seed

Medical organization in Ann Arbor, MI since 2006.

HQ
Ann Arbor, MI, US
Founded
2006
Overview
Compare
Fundraising
Employees

FST Life Sciences, Inc. was incorporated

in 2006 and is based in Ann Arbor, Michigan.

FST Life Sciences - Similar Companies

Tesla Life Sciences logo

Tesla Life Sciences

ISI Life Sciences logo

ISI Life Sciences

FibrosIX logo

FibrosIX

Fortis Biosciences logo

Fortis Biosciences

Starr Life Sciences logo

Starr Life Sciences

ZetaRx Biosciences logo

ZetaRx Biosciences

Fluidigm logo

Fluidigm

standardbio.com

Westwood Life Sciences logo

Westwood Life Sciences

Fast Biomedical logo

Fast Biomedical

Facet Life Sciences logo

Facet Life Sciences

Amplified Sciences logo

Amplified Sciences

Turek Labs logo

Turek Labs

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

FTL Labs logo

FTL Labs

ftllabscorp.com

FST Life Sciences - Quick Facts

Who are FST Life Sciences' competitors?

Companies similar to FST Life Sciences include Tesla Life Sciences, ISI Life Sciences, FibrosIX and Fortis Biosciences.

When was FST Life Sciences founded?

FST Life Sciences was founded in 2006.

Where is FST Life Sciences' headquarters located?

FST Life Sciences' headquarters is located in Ann Arbor, MI, US.

When was FST Life Sciences' last funding round?

FST Life Sciences' most recent funding round was for $1.1M (USD) in September 2010.

How much has FST Life Sciences raised to-date?

As of Sep 15, 2010, FST Life Sciences has raised a total of $1.1M (USD).

How many employees does FST Life Sciences have?

FST Life Sciences has 5 employees as of Feb 5, 2024.

FST Life Sciences - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical
Tags
  • Software
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified